Northwest Biotherapeutics presents updated DCVax-L Phase III trial survival data for glioblastoma

Lynk Pharmaceuticals reports first patient dosed in Phase II clinical trial for vitiligo treatment

HanchorBio plans combination research with late-stage cancer drug resistance specialist InxMed

Keenova reports positive Phase 3 results for XIAFLEX in plantar fibromatosis

GE HealthCare and Mayo Clinic launch prostate cancer theranostics research study

Helix partners with AstraZeneca to support genomic research for drug discovery and development

Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis

Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection

Wiley announces launch of Advanced Immunology open access journal

Ascletis submits two IND applications to US FDA for obesity treatments

AbbVie's TEPKINLY (epcoritamab) combination approved in Europe to treat relapsed or refractory follicular lymphoma

Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

Brii Bio reports Phase 2 end-of-treatment data in chronic hepatitis B